D. Neau

B. Masquelier, D. Neau, J. Ragnaud, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Carotid intima–media thickness is slightly increased over time in HIV‐1‐infected patients *

D. Neau, S. Lawson-Ayayi, M. Dupon, 2005, HIV medicine.

Thrombotic thrombocytopenic purpura and cytomegalovirus infection in an immunocompetent adult.

D. Neau, F. Bonnet, M. Longy-Boursier, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rhabdomyolysis and Salmonella enteritidis Infection

D. Neau, J. Ragnaud, M. E. El Kadiri, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

Extra-rectal lymphogranuloma venereum in France: a clinical and molecular study

D. Neau, A. Desclaux, C. Bébéar, 2017, Sexually Transmitted Infections.

Prevalence of Mycoplasma genitalium among HIV-infected women, Agence Nationale de Recherches sur le SIDA et les hépatites virales CO3 Aquitaine Cohort, France.

D. Neau, S. Lawson-Ayayi, P. Morlat, 2013, Sexually transmitted diseases.

Knowledge, behaviors, and attitudes of HIV-infected men about syphilis.

V. Gaborieau, D. Neau, F. Dabis, 2017, Medecine et maladies infectieuses.

False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers.

É. Oksenhendler, C. Katlama, D. Neau, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical and laboratory findings of cytomegalovirus infection in 115 hospitalized non-immunocompromised adults.

D. Neau, J. Ragnaud, M. Dupon, 2001, Annales de medecine interne.

Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment

D. Neau, F. Dabis, J. Moreau, 1998, AIDS.

Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.

D. Neau, P. Morlat, C. Michelet, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

CD4+ lymphocyte count and plasma HIV RNA levels in a survey of 1602 HIV-infected patients in Bordeaux, France, 1996-1997. Groupe d'Epidemiologie Clinique da SIDA en Aquitaine.

D. Neau, J. Moreau, D. Malvy, 1998, AIDS (London).

Epidemic of complicated mumps in previously vaccinated young adults in the South-West of France.

D. Neau, P. Duffau, M. Lafon, 2014, Medecine et maladies infectieuses.

Dual nucleoside regimens in nonadvanced HIV infection: prospective follow-up of 130 patients, Aquitaine Cohort, 1996 to 1998. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

D. Neau, P. Morlat, F. Dabis, 2000 .

Severe Morbidity According to Sex in the Era of Combined Antiretroviral Therapy: The ANRS CO3 Aquitaine Cohort

D. Neau, P. Morlat, F. Dabis, 2014, PloS one.

Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine.

D. Neau, M. Dupon, P. Morlat, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pre- and In-Hospital Management of Community-Acquired Pneumonia in Southern France, 1998–99

S. Badiaga, D. Neau, A. Sotto, 2001, European Journal of Clinical Microbiology & Infectious Diseases.

Chronic Viral Hepatitis Is Associated With Low Bone Mineral Density in HIV-Infected Patients, ANRS CO 3 Aquitaine Cohort

D. Neau, S. Lawson-Ayayi, M. Dupon, 2013, Journal of acquired immune deficiency syndromes.

HIV infection and tobacco smoking behaviour: prospects for prevention? ANRS CO3 Aquitaine Cohort, 2002.

D. Neau, F. Dabis, E. Lazaro, 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients

A. d’Arminio Monforte, H. Günthard, E. Bernasconi, 2019, Open forum infectious diseases.

Limbic encephalitis as a relapse of Whipple’s disease with digestive involvement and spondylodiscitis

D. Raoult, H. Lepidi, D. Neau, 2018, Infection.

A Low Level of Darunavir Resistance–Associated Mutation Emergence in Patients With Virological Failure During Long-term Use of Darunavir in People With HIV. The ANRS CO3 Aquitaine Cohort

D. Neau, E. Lazaro, P. Bellecave, 2020, Open forum infectious diseases.

Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus.

C. Katlama, D. Neau, P. Morlat, 2020, Clinical Infectious Diseases.

Atteinte cardiaque au cours du syndrome primaire des anticorps antiphospholipides : 6 observations

D. Neau, J. Pellegrin, B. Leng, 1992 .

Validation and Comparison of Simple Noninvasive Indexes for Predicting Liver Fibrosis in HIV-HCV-Coinfected Patients: ANRS CO3 Aquitaine Cohort

D. Neau, F. Dabis, P. Bioulac-Sage, 2008, The American Journal of Gastroenterology.

Nucleic acid amplification testing detection of an HIV‐1 infection in a blood donor during the preseroconversion window period

D. Neau, H. Fleury, S. Laperche, 2007, Transfusion medicine.

Comparison of 2 regimens that include interferon-alpha-2a plus ribavirin for treatment of chronic hepatitis C in human immunodeficiency virus-coinfected patients.

D. Neau, J. Ragnaud, M. Dupon, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Common variable immunodeficiency: 17 observations in the adult].

D. Neau, J. Moreau, J. Viallard, 2003, La Revue de medecine interne.

Absence of Decline of Kidney Function in Human Immunodeficiency Virus-Infected Patients Under Routine Clinical Management

D. Neau, S. Lawson-Ayayi, M. Dupon, 2017, Nephron.

Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.

C. Katlama, D. Neau, P. Morlat, 2019, European journal of gastroenterology & hepatology.

[A rare cause of paroxysmal eosinophilia: eosinophilic gastroenteritis].

D. Neau, E. Monlun, M. Longy-Boursier, 1995, La Revue de medecine interne.

Hepatic steatosis in HIV‐HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype

V. de Lédinghen, D. Neau, F. Dabis, 2007, Alimentary pharmacology & therapeutics.

Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: the Aquitaine cohort, 1996-2001.

Hélène Jacqmin-Gadda, Roger Salamon, Rodolphe Thiébaut, 2003, Journal of acquired immune deficiency syndromes.

Structure-Analysis of the HIV-1 Integrase Y143C/R Raltegravir Resistance Mutation in Association with the Secondary Mutation T97A

M. Laguerre, B. Masquelier, D. Neau, 2011, Antimicrobial Agents and Chemotherapy.

Structure analysis of HIV-1 IN Y143C/R Raltegravir resistance mutation in association

C. Calmels, H. Fleury, M. Laguerre, 2011 .

Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort

M. Ziol, C. Delaugerre, C. Katlama, 2020 .

Mechanism of Virologic Failure After Substitution of a Protease Inhibitor by Nevirapine in Patients With Suppressed Plasma HIV‐1 RNA

B. Masquelier, D. Neau, G. Chêne, 2001, Journal of acquired immune deficiency syndromes.

Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients.

D. Breilh, D. Neau, J. Ragnaud, 2009, Journal of acquired immune deficiency syndromes.

HIV Type-1 Transmission Dynamics in Recent Seroconverters: Relationship with Transmission of drug Resistance and Viral Diversity

B. Masquelier, D. Neau, P. Morlat, 2008, Antiviral therapy.

Tobacco, alcohol, cannabis, and illicit drug use and their association with CD4/CD8 cell count ratio in people with controlled HIV: a cross-sectional study (ANRS CO3 AQUIVIH-NA-QuAliV)

V. Gaborieau, D. Breilh, D. Neau, 2023, BMC Infectious Diseases.

A comprehensive analysis of excess depressive disorder in women and men living with HIV in France compared to the general population

V. Gaborieau, D. Neau, E. Lazaro, 2022, Scientific Reports.

Pharmacokinetics and Resistance Mutations Affect Virologic Response to Ritonavir/Saquinavir-Containing Regimens

D. Breilh, D. Neau, H. Fleury, 2001, Therapeutic drug monitoring.

[Primary prophylaxis against cerebral toxoplasmosis. Efficacy of folinic acid in the prevention of hematologic toxicity of pyrimethamine].

D. Neau, J. Pellegrin, B. Leng, 1994, Presse medicale.

HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998-2008.

D. Neau, P. Morlat, F. Dabis, 2011, Journal of hepatology.

Efficacy, safety and patient‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)

V. de Lédinghen, Y. Yazdanpanah, D. Neau, 2018, HIV medicine.

Giant cell arteritis involving the lower limbs.

D. Neau, P. Mercié, C. Conri, 1997, Revue du rhumatisme.

Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)

M. Ziol, C. Delaugerre, C. Katlama, 2022, JHEP reports : innovation in hepatology.

Multicenter Retrospective Study of Vascular Infections and Endocarditis Caused by Campylobacter spp., France

Claire L. Webster, D. Neau, E. Bille, 2023, Emerging infectious diseases.

Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort’s QuAliV ancillary study

D. Neau, F. Dabis, E. Lazaro, 2020, Health and Quality of Life Outcomes.

Changing utilization of Stavudine (d4T) in HIV‐positive people in 2006–2013 in the EuroSIDA study

J. Nielsen, C. Leen, P. Vanhems, 2015, HIV medicine.

Factors associated with being overweight and obesity in people living with HIV on antiretroviral therapy : socio-clinical, inflammation, and metabolic markers.

A. Maignan, Y. Yazdanpanah, D. Neau, 2021, The Journal of infectious diseases.

[Educational assessment of the first computerized national ranking exam in France in 2016: Opportunities for improvement].

D. Neau, P. Dehail, J. Constans, 2019, La Revue de medecine interne.

Impact of hepatitis C cure on risk of mortality and morbidity in people with HIV after antiretroviral therapy initiation

J. Sterne, J. Rockstroh, D. Neau, 2023, AIDS.

Alternative methods to analyse the impact of HIV mutations on virological response to antiviral therapy

D. Commenges, D. Breilh, D. Neau, 2008 .

Prevalence and factors associated with renal impairment in HIV‐infected patients, ANRS C03 Aquitaine Cohort, France

D. Neau, S. Lawson-Ayayi, M. Dupon, 2010, HIV medicine.

Outcomes of targeted treatment in immunocompromised patients with asymptomatic or mild COVID-19: a retrospective study

V. de Lédinghen, D. Neau, S. Pédeboscq, 2023, Scientific reports.

Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.

E. Bernasconi, P. Reiss, J. Dufour, 2019, Journal of hepatology.

[Clinical, microbiological, and therapeutic aspects of Nocardia sp. infections in the Bordeaux hospital from 1993 to 2003].

D. Neau, J. Ragnaud, C. Bébéar, 2006, Medecine et maladies infectieuses.